TCL Archive CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round November 20, 1981
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012